Search Results

In this webinar, BioSpace will gather experts to discuss China’s impact on the future of biotech and how both U.S. and Chinese companies can thrive—and maybe even collaborate.

Disease control observed in all three patients at the first and lowest dose level, supporting continued dose escalation

New name, visual identity and website position Ann Arbor preclinical CRO for its next phase of scientific growth

The new site strengthens the company’s production capacity, sustainable industrial footprint, and support for global bioprocessing customers. • New 4,200 m² headquarters and manufacturing facility located within the Biopôle Clermont-Limagne life sciences technology park • Designed to increase manufacturing capacity by 150% for the company’s downstream purification technologies • Selected as part of the France 2030 “Industrialization and Health Capacities 2030” program • Sustainable features include photovoltaic panels, green roofing, rainwater recovery and reuse, and electric vehicle charging stations

Successful completion of GLP toxicology analysis for the intravenous administration of Rutherrin(R) lays the groundwork for regulatory submissions supporting first-in-human clinical development for multiple life-threatening cancers

Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical Synthesis Format expansion shows how BioHarvest can help CDMO partners move from plant-cell compositions to differentiated consumer products

Proprietary TeloView® blood-based TELO-MRD assay detected residual myeloma cells in a higher proportion of matched samples than bone-marrow next-generation flow cytometry in a University of Athens comparison.